No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy
-
Bone Marrow / pathology
-
Bone Marrow Cells / metabolism
-
Bone Marrow Cells / pathology
-
Cell Differentiation / genetics*
-
Child, Preschool
-
Humans
-
Immunophenotyping
-
Leukemia, Myelomonocytic, Acute / diagnosis
-
Leukemia, Myelomonocytic, Acute / drug therapy
-
Leukemia, Myelomonocytic, Acute / genetics*
-
Leukemia, Myelomonocytic, Acute / pathology*
-
Male
-
Neoplasm Grading
-
Nucleophosmin
-
Oncogene Proteins, Fusion / genetics*
-
Oncogene Proteins, Fusion / metabolism
-
Translocation, Genetic*
-
Treatment Outcome
Substances
-
NPM-RARalpha protein, human
-
NPM1 protein, human
-
Oncogene Proteins, Fusion
-
Nucleophosmin